Insulin Recombinant Human Patent Expiration
Insulin Recombinant Human is Used for treating diabetes mellitus through inhalation of a dry powder medicament containing insulin. It was first introduced by Eli Lilly And Co
Insulin Recombinant Human Patents
Given below is the list of patents protecting Insulin Recombinant Human, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Afrezza | US10046031 | Use of ultrarapid acting insulin | Aug 11, 2029 | Mannkind |
| Afrezza | US10201672 | Dry powder inhaler and system for drug delivery | Aug 02, 2030 | Mannkind |
| Afrezza | US10342938 | Dry powder drug delivery system | Jun 12, 2029 | Mannkind |
| Afrezza | US10500159 | Apparatus and method for cryogranulating a pharmaceutical composition | Nov 02, 2030 | Mannkind |
| Afrezza | US6071497 | Microparticles for lung delivery comprising diketopiperazine |
May 15, 2015
(Expired) | Mannkind |
| Afrezza | US6428771 | Method for drug delivery to the pulmonary system |
May 15, 2015
(Expired) | Mannkind |
| Afrezza | US6444226 | Purification and stabilization of peptide and protein pharmaceutical agents |
Jun 29, 2020
(Expired) | Mannkind |
| Afrezza | US6652885 | Purification and stabilization of peptide and protein pharmaceutical agents |
Jun 29, 2020
(Expired) | Mannkind |
| Afrezza | US6663898 | Carbon-substituted diketopiperazine delivery systems |
Sep 30, 2014
(Expired) | Mannkind |
| Afrezza | US6906030 | Carbon-substituted diketopiperazine delivery systems |
Sep 30, 2014
(Expired) | Mannkind |
| Afrezza | US7276534 | Carbon-substituted diketopiperazine delivery systems |
Sep 30, 2014
(Expired) | Mannkind |
| Afrezza | US7305986 | Unit dose capsules for use in a dry powder inhaler |
Jan 16, 2023
(Expired) | Mannkind |
| Afrezza | US7464706 | Unit dose cartridge and dry powder inhaler |
Mar 02, 2023
(Expired) | Mannkind |
| Afrezza | US7648960 | Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
Jun 29, 2020
(Expired) | Mannkind |
| Afrezza | US7943178 | Methods and compositions for delivering peptides |
Jun 29, 2020
(Expired) | Mannkind |
| Afrezza | US7943572 | Superior control of blood glucose in diabetes treatment | Aug 10, 2026 | Mannkind |
| Afrezza | US8119593 | Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin | Aug 11, 2029 | Mannkind |
| Afrezza | US8133514 | Carbon-substituted diketopiperazine delivery systems |
Sep 30, 2014
(Expired) | Mannkind |
| Afrezza | US8146588 | Unit dose capsules and dry powder inhaler |
Apr 24, 2023
(Expired) | Mannkind |
| Afrezza | US8156936 | Unit dose capsules and dry powder inhaler |
Jan 16, 2023
(Expired) | Mannkind |
| Afrezza | US8215300 | Unit dose cartridge and dry powder inhaler |
Nov 24, 2022
(Expired) | Mannkind |
| Afrezza | US8227409 | Diketopiperazine microparticles with defined isomer contents | Mar 08, 2031 | Mannkind |
| Afrezza | US8258095 | Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content | Aug 11, 2029 | Mannkind |
| Afrezza | US8389470 | Methods and compositions for delivering peptides |
Jun 29, 2020
(Expired) | Mannkind |
| Afrezza | US8394414 | Method for drug delivery to the pulmonary system |
May 15, 2015
(Expired) | Mannkind |
| Afrezza | US8424518 | Dry powder inhaler and system for drug delivery | Oct 17, 2031 | Mannkind |
| Afrezza | US8485180 | Dry powder drug delivery system | Mar 25, 2030 | Mannkind |
| Afrezza | US8499757 | Dry powder inhaler and system for drug delivery | Feb 19, 2032 | Mannkind |
| Afrezza | US8551528 | Diketopiperazine microparticles with defined specific surface areas | Jun 11, 2030 | Mannkind |
| Afrezza | US8623817 | Method of treating diabetes type 2 by administering ultrarapid acting insulin | Sep 18, 2029 | Mannkind |
| Afrezza | US8636001 | Dry powder inhaler and system for drug delivery | Jul 12, 2032 | Mannkind |
| Afrezza | US8729019 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents | Dec 26, 2028 | Mannkind |
| Afrezza | US8734845 | Diketopiperazine microparticles with defined specific surface areas | Jun 11, 2030 | Mannkind |
| Afrezza | US8778403 | Diketopiperazine microparticles with defined specific surface areas | Jun 11, 2030 | Mannkind |
| Afrezza | US8889099 | Methods and compositions for delivering peptides |
Jun 29, 2020
(Expired) | Mannkind |
| Afrezza | US8912193 | Dry powder inhaler and system for drug delivery | Jun 12, 2029 | Mannkind |
| Afrezza | US8950397 | Unit dose cartridge and dry powder inhaler |
Jul 20, 2021
(Expired) | Mannkind |
| Afrezza | US9192675 | Dry powder inhaler and system for drug delivery | Jun 12, 2029 | Mannkind |
| Afrezza | US9283193 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents | Sep 14, 2026 | Mannkind |
| Afrezza | US9339615 | Dry powder inhaler and system for drug delivery | Oct 20, 2029 | Mannkind |
| Afrezza | US9358352 | Dry powder drug delivery system and methods | Feb 15, 2031 | Mannkind |
| Afrezza | US9393372 | Dry powder drug delivery system | Jul 04, 2029 | Mannkind |
| Afrezza | US9446133 | Dry powder inhaler and system for drug delivery | Jun 12, 2029 | Mannkind |
| Afrezza | US9511198 | Dry powder inhaler and system for drug delivery | Feb 16, 2030 | Mannkind |
| Afrezza | US9597374 | Use of ultrarapid acting insulin | Oct 08, 2031 | Mannkind |
| Afrezza | US9662461 | Dry powder drug delivery system and methods | Jun 12, 2029 | Mannkind |
| Afrezza | US9717689 | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents | Sep 14, 2026 | Mannkind |
| Afrezza | US9943571 | Use of ultrarapid acting insulin | Aug 11, 2029 | Mannkind |
| Exubera | US5740794 | Apparatus and methods for dispersing dry powder medicaments |
Apr 21, 2015
(Expired) | Pfizer |
| Exubera | US5997848 | Methods and compositions for pulmonary delivery of insulin |
Mar 07, 2014
(Expired) | Pfizer |
| Exubera | US6051256 | Dispersible macromolecule compositions and methods for their preparation and use |
Mar 07, 2014
(Expired) | Pfizer |
| Exubera | US6257233 | Dry powder dispersing apparatus and methods for their use |
May 14, 2019
(Expired) | Pfizer |
| Exubera | US6423344 | Dispersible macromolecule compositions and methods for their preparation and use |
Mar 07, 2014
(Expired) | Pfizer |
| Exubera | US6543448 | Apparatus and methods for dispersing dry powder medicaments |
Sep 21, 2014
(Expired) | Pfizer |
| Exubera | US6546929 | Dry powder dispersing apparatus and methods for their use |
May 14, 2019
(Expired) | Pfizer |
| Exubera | US6582728 | Spray drying of macromolecules to produce inhaleable dry powders |
Jun 24, 2020
(Expired) | Pfizer |
| Exubera | US6592904 | Dispersible macromolecule compositions and methods for their preparation and use |
Mar 07, 2014
(Expired) | Pfizer |
| Exubera | US6685967 | Methods and compositions for pulmonary delivery of insulin |
Sep 11, 2018
(Expired) | Pfizer |
| Exubera | US6737045 | Methods and compositions for the pulmonary delivery insulin |
Mar 07, 2014
(Expired) | Pfizer |
| Humulin R | US7291132 | Medication dispensing apparatus with triple screw threads for mechanical advantage | Aug 09, 2024 | Lilly |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳